It is reported that "Presumed Medical" has recently completed D1 round of financing. This round of financing was led by Zhongguancun M&A Fund of Funds, with Zhongguancun Science City, Shenzhen Yicun Tongsheng, Shanghai Lianyi and old shareholders. This is a new round of financing following the 300 million yuan C round of financing from Shanghui Capital, Yuansheng Capital, Sequoia Capital China, Qiming Venture Capital, and Xianghe Capital in 2018.
"Presumed Medical" is a technology company that uses artificial intelligence for medical services. Based on medical imaging data, it analyzes and compares the corresponding clinical data, including clinical reports and laboratory research data, mining the correlations behind the data, and providing medical solutions Program.
10 days ago, it is assumed that the lung nodule AI product was approved by the National Medical Products Administration (NMPA) Medical Device Class III certificate, becoming the only NMPA approved lung AI product. At the same time, it is assumed that Lung AI is also the first FDA-approved lung auxiliary test product based on deep learning. "Presumed Medical" has also become the only AI medical company in the world that has been approved to have access to the four major markets with EU CE certification, Japan PMDA medical device certification, US FDA certification and China's NMPA's first lung AI three-category certificate.
InferRead CT Lung Disease Intelligent Solution
The platform developed by "Inferential Medical" includes InferScholarAI academic research platform, InferSight image big data intelligent analysis platform and InferMatrixTMAI product and algorithm integration platform including medical AI full-process platform; solutions include lung Disease intelligent solution InferRead CT Lung, chest disease intelligent solution InferRead DR Chest, stroke solution InferRead CT Stroke, bone disease solution InferRead CT Bone, breast disease solution InferRead MG Breast, and children's growth and development intelligent solution InferRead DR.
InferSight image big data intelligent analysis platform
According to the official website data, as of October 2020, the implementation of "Presumed Medical" AI has covered 33 provincial administrative regions across the country. While expanding the Chinese medical market, "Predictive Medical" has also completed its strategic layout in North America, Asia Pacific and Europe. AI services have covered 10 countries around the world, with an average of 64,000 AI quality control operations per day, and the total number of completed cases has exceeded 26,000. More than 000 cases.
Editor: Cai Shuning
